IndraLab
Statements
reach
"mTOR inhibition prevents negative feedback mechanisms; in one of these S6K1 phosphorylates IRS-1 (insulin receptor substrate-1) causing it to dissociate from tyrosine kinase receptors; in another mTORC1 phosphorylates GRB10 which suppresses insulin and IGF receptor kinase activity and facilitates their degradation; and in a third mTORC2 assembly is prevented by phosphorylation of Sin1, mediated by S6K or Akt depending on the cell type."
sparser
"In our study, we found that mTORC2 deficiency could lead to increased mTORC1 activity under certain conditions [ xref , xref ] (data not shown), while over-activation of mTORC1 also restricts mTORC2 activity, either through the mTORC1-mediated phosphorylation and activation of Grb10, a negative regulator of insulin/IGF-1 receptor [ xref , xref ], or by S6K1 phosphorylation and degradation of insulin receptor substrate 1 (IRS1) to suppress mTORC2 activity [ xref ]."
sparser
"As a negative-feedback loop exists in which S6K1 directly phosphorylates IRS1 (insulin receptor substrate protein 1) and blocks IGF-1 (insulin-like growth factor 1) signaling to PI3K xref , a major drawback of selectively inhibiting mTOR is the consequent activation of PI3K, which can ultimately enhance tumor growth xref ."
sparser
"Whereas mTORC2 directly phosphorylates AKT, activated p70S6K phosphorylates and negatively regulates insulin receptor substrate 1. xref As insulin receptor substrate 1 is an important upstream activator of PI3K–AKT, phosphorylation of p70S6K, thus, evokes a physiological negative feedback loop toward AKT. xref Phosphorylation of AKT at Ser 473 was slightly attenuated in 3T3 cells expressing active mTOR mutants compared with that in those expressing the wild‐type protein (Fig. xref a), consistent with a previous observation. xref "
sparser
"As shown in xref , p-S6K1 (T389) was increased in LKB1-deficient WAT whereas the levels of p-IRS1 (Ser636/639) in WAT from LKB1 −/− were reduced when compared with WT, suggesting that increased Akt inhibition in LKB1-deficient WAT was not due to increased phosphorylation of IRS1 by S6K1."
sparser
"In addition, when mTORC1 is activated, S6K1 could directly phosphorylate Insulin receptor substrate 1 (IRS1; S307 and S636/S639) and promote its degradation, which subsequently blunts phosphoinositide 3-kinase (PI3K)-AKT activation and its downstream effects such as glucose uptake and glycogen accumulation ( xref ; xref )."
reach
"To control the extent of mTORC1 activation and restore TSC regulation after this stimulus, the mTORC1 substrate S6K1 then directly phosphorylates insulin receptor substrate 1 (IRS-1) as part of a negative feedback loop, blocking the further insulin mediated activation of the PI3K-AKT pathway [XREF_BIBR, XREF_BIBR]."
sparser
"Studies in cultured myotubes and isolated rat skeletal muscles suggest that Leu and BCAA can impair insulin-mediated glucose uptake through a negative-feedback loop (Iwanaka et al. 2010; xref ), presumably mediated by mTOR-S6K1 phosphorylation and subsequent serine phosphorylation and inactivation of IRS-1 (Iwanaka et al. 2010; xref )."
reach
"As shown in XREF_FIG, p-S6K1 (T389) was increased in LKB1 deficient WAT whereas the levels of p-IRS1 (Ser636/639) in WAT from LKB1 -/- were reduced when compared with WT, suggesting that increased Akt inhibition in LKB1 deficient WAT was not due to increased phosphorylation of IRS1 by S6K1."
sparser
"In humans, acute supplementation with protein has been shown to be insulinotropic. xref , xref , xref It has been suggested that the insulinotropic effect of leucine is mediated by stimulation of protein synthesis in pancreatic β cells by the mTOR signaling pathway. xref This pathway mediates insulin resistance by phosphorylation of IRS-1 by S6K1."
reach
"As a negative-feedback loop exists in which S6K1 directly phosphorylates IRS1 (insulin receptor substrate protein 1) and blocks IGF-1 (insulin like growth factor 1) signaling to PI3K 107, a major drawback of selectively inhibiting mTOR is the consequent activation of PI3K, which can ultimately enhance tumor growth 108."
sparser
"Prompted by the results from intravenous amino acid infusion studies in people that demonstrated that amino acids blunt insulin-mediated glucose disposal ( xref , xref ) and studies conducted in cultured myotubes and isolated rat skeletal muscles that demonstrated that leucine can impair insulin-mediated glucose uptake ( xref , xref ), presumably mediated by mTOR-p70S6K phosphorylation and subsequent serine phosphorylation of insulin receptor substrate-1 ( xref ), we tested the hypothesis that protein ingestion impairs insulin-mediated glucose disposal by leucine-mediated muscle mTOR signaling in people."
sparser
"P70S6K is activated in the insulin-signaling pathway via AKT phosphorylation of mTOR, which in turn phosphorylates and activates p70S6K. A well defined negative signaling pathway has been described involving negative phosphorylation of IRS-1 by p70S6K, leading to insulin induced degradation of IRS-1 ( xref ; xref )."
reach
"IL-6 activates S6K1 in these cells, but unexpectedly, S6K1 is not involved in IL-6 inhibition of insulin signaling, since the effect of IL-6 persists in cells with drastically reduced S6K1 levels induced by RNA interference, suggesting that the function of mTOR signaling is through a mechanism different from the prevailing model of S6K1 phosphorylation of insulin receptor substrate-1."
sparser
"However, S6K1 has multiple substrates. xref For example, S6K1 phosphorylates eEF2K to enhance protein synthesis, xref and the cell growth regulator SKAR (S6K1 Aly/REF-like target) has also been identified as a substrate for S6K1, but not for S6K2. xref S6K1 also phosphorylates insulin receptor substrate 1 (IRS1) xref and mTOR xref in response to nutrients and growth factors, albeit in a feedback fashion."